Interleukin-33 and interleukin-10 expression in proliferative diabetic retinopathy

Keywords: diabetic retinopathy, IL-33, IL-10, cytokines, inflammation

Abstract

Diabetic retinopathy is associated with immune dysregulation driven by chronic hyperglycemia. The role of cytokine balance in its progression remains incompletely understood. To evaluate IL-33 and IL-10 levels and their ratios in patients with diabetic retinopathy depending on disease stage and metabolic control. Patients with proliferative and non-proliferative diabetic retinopathy were stratified by compensated and decompensated diabetes. IL-33 and IL-10 concentrations were measured by ELISA, and IL-33/IL-10 and IL-10/IL-33 ratios were calculated. IL-33 levels did not differ significantly between groups (p>0.05), although a decreasing trend was observed in non-proliferative diabetic retinopathy with compensated diabetes. IL-10 levels were significantly higher in non-proliferative diabetic retinopathy compared with proliferative (p<0.05). The IL-33/IL-10 ratio was increased in proliferative, indicating higher pro-inflammatory potential, while it was reduced in non-proliferative diabetic retinopathy with decompensated diabetes. Conversely, the IL-10/IL-33 ratio was elevated in decompensated diabetes regardless of retinopathy stage (p<0.05). Cytokine balance between IL-33 and IL-10 depends on both disease stage and metabolic control. IL-10 may exhibit context-dependent pro-inflammatory effects in decompensated diabetes. Cytokine ratios may serve as potential biomarkers of immune dysregulation in diabetic retinopathy.

Published
2026-09-30
How to Cite
Sarakhman, Dmytro, Lyubov Lapovets, Sergii Tkachuk, Viorika Akimova, Marta Horecha, Olga Buchko, Lolita Vorontsova, Halyna Lebed, Sofiia Rafaliuk, and Nataliia Kozopas. 2026. “Interleukin-33 and Interleukin-10 Expression in Proliferative Diabetic Retinopathy”. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 33 (3), 406-10. https://rjdnmd.org/index.php/RJDNMD/article/view/2192.